Background: Powassan virus is an emerging neurotropic arbovirus transmitted by the tick This systematic review was conducted to aggregate data on its clinical manifestations, diagnostic findings, and complications.

Methods: PubMed was searched until August 2023 using the term "Powassan", to identify all published cases of Powassan virus infections, as per PRISMA guidelines.

Results: Among the 380 abstracts identified, 45 studies describing 84 cases (70 adult, 14 pediatric) were included. Cases were reported from the USA and Canada. Complications included paralysis in 44.1% of adult and 42.6% of pediatric cases, cognitive deficits in 33.3% of adult and 25% of pediatric cases, while the mortality rate was 19.1% and 7.1% in the adult and pediatric populations, respectively. Correlation analysis revealed an association between mortality and age (r = 0.264, = 0.029), development of paralysis (r = 0.252, = 0.041), or respiratory distress or failure (r = 0.328, = 0.006). Factors associated with persistent neurological deficits were development of ataxia (r = 0.383, = 0.006), paralysis (r = 0.278, = 0.048), speech disorder (r = 0.319, = 0.022), and cranial nerve involvement (r = 0.322, = 0.017). Other significant correlations included those between speech disorders and ataxia (r = 0.526, < 0.001), and between paralysis and respiratory distress or failure (r = 0.349, = 0.003).

Conclusion: Powassan virus infections have significant morbidity and mortality and should be suspected in cases of encephalitis and possible tick exposure. PROSPERO registration number: CRD42023395991.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10747444PMC
http://dx.doi.org/10.3390/tropicalmed8120508DOI Listing

Publication Analysis

Top Keywords

powassan virus
16
virus infections
12
systematic review
8
published cases
8
adult pediatric
8
pediatric cases
8
respiratory distress
8
distress failure
8
cases
7
powassan
4

Similar Publications

Whole-genome sequencing surveillance of Siberian tick-borne encephalitis virus (TBEV) identifies an additional lineage in Kyrgyzstan.

Virus Res

December 2024

UK Health Security Agency, Science Group, Porton Down, Salisbury, UK; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK; Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection and Veterinary and Ecological Science, University of Liverpool, Liverpool, UK.

Tick-borne encephalitis virus (TBEV) is the most prevalent tick-borne viral disease in Europe and Asia. There are three main subtypes of the virus: European, Siberian, and Far Eastern, each of which having distinctive ecology, clinical presentation, and geographic distribution. In recent years, other TBEV subtypes have been described, namely the Himalayan and Baikalian subtypes.

View Article and Find Full Text PDF

Powassan virus (POWV) is a pathogenic tick-borne flavivirus that causes fatal neuroinvasive disease in humans. There are currently no approved therapies or vaccines for POWV infection. Here, we develop a POW virus-like-particle (POW-VLP) based vaccine adjuvanted with the novel synthetic Toll-like receptor 7/8 agonist INI-4001.

View Article and Find Full Text PDF
Article Synopsis
  • - Ticks are a major vector for diseases like Lyme disease and tick-borne encephalitis in China, prompting researchers to study the variety and spread of viruses they carry in Inner Mongolia from March 2021 to May 2023.
  • - Through advanced sequencing methods, the study identified 20 RNA viruses from eight families, including several that can infect humans, with Ixodes persulcatus being the tick species with the highest viral diversity.
  • - The research highlights significant regional differences in the presence of these viruses and the complexities of coinfection among different tick species, emphasizing the need for ongoing surveillance of tick-borne diseases.
View Article and Find Full Text PDF

Reported tick-borne-encephalitis (TBE) cases have been increasing in Western Austria, but no data are available on vaccination- and infection-specific seroprevalence. This study aimed to estimate current TBEV-seroprevalence in the region and inform prevention programs by comparing anti-NS1-based-incidence rates with reported case numbers and vaccination coverage. Between December 2023 and February 2024, serum samples from 4619 blood donors in Western Austria were collected and analyzed using TBEV- and WNV-IgG-ELISA assays.

View Article and Find Full Text PDF

Multi-protomics analysis identified host cellular pathways perturbed by tick-borne encephalitis virus infection.

Nat Commun

November 2024

Department of Infectious Diseases and Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, The First Hospital of Jilin University, Changchun, China.

Tick-borne encephalitis virus (TBEV) represents a pivotal tick-transmitted flavivirus responsible for severe neurological consequences in Europe and Asia. The emergence of TBEV genetic mutations and vaccine-breakthrough infections, along with the absence of effective vaccines and specific drugs for other tick-borne flaviviruses associated with severe encephalitis or hemorrhagic fever, underscores the urgent need for progress in understanding the pathogenesis and intervention strategies for TBEV and related flaviviruses. Here we elucidate cellular alterations in the proteome, phosphoproteome, and acetylproteome upon TBEV infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!